Seed Therapeutics News and Activities

Seed Therapeutics is owned by BeyondSpring.

BeyondSpring is a company listed under the stock ticker BYSI (US).

Acquisition, funding and merger involving BeyondSpring.

• Seed Therapeutics has just announced a $30 Million fundraising (posted on October 31 2025).

View the org chart displaying its 16 main executives

Most searched biographies at Seed Therapeutics

• Lan Huang, Chief Executive Officer
• Yoshiharu Mizui, Director
• Linus Lin, Director

Popular executive movements at BeyondSpring

• Min Qiu will join the company as Chief Executive Officer on Jul. 1, 2026  (posted on June 4 2026).
• Jiangwen Majeti who is Director, will become Vice Chairman of the Board on Jul. 1, 2026  (posted on June 4 2026).
• Na Li will join the company as Chief Financial Officer on Jul. 1, 2026  (posted on June 4 2026).

Click here to view some more movements at BeyondSpring

Create your alert
to follow the executive moves at Seed Therapeutics.

BeyondSpring has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Seed Therapeutics

• Investors & Media | SEED Therapeutics News and Financial Updates

Social media about Seed Therapeutics

• Seed Therapeutics on Wikipedia, Google News & Yahoo Finance
• Seed Therapeutics on LinkedIn, X (Twitter) & YouTube